This list is based on the watchlists of people on Stock Events who follow PLRZ. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
FAQs
What is Polyrizon stock price today?▼
The current price of PLRZ is $10.75 USD — it has increased by +19.4% in the past 24 hours. Watch Polyrizon stock price performance more closely on the chart.
What is Polyrizon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Polyrizon stocks are traded under the ticker PLRZ.
Is Polyrizon stock price growing?▼
PLRZ stock has risen by +20.02% compared to the previous week, the month change is a +11.86% rise, over the last year Polyrizon has showed a +75.65% increase.
What is Polyrizon market cap?▼
Today Polyrizon has the market capitalization of 26.11M
What is Polyrizon revenue for the last year?▼
Polyrizon revenue for the last year amounts to 0 USD.
What is Polyrizon net income for the last year?▼
PLRZ net income for the last year is -3.34M USD.
How many employees does Polyrizon have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Polyrizon located?▼
Polyrizon operates in the Health & Wellness sector.
When did Polyrizon complete a stock split?▼
The last stock split for Polyrizon was on November 28, 2025 with a ratio of 1:6.
Where is Polyrizon headquartered?▼
Polyrizon is headquartered in Ra'anana, Israel.